🔎 Trials Near Me

Gara Jalqabaatti › Myelofibrosis › Alabama

Qorannoo klinikaalii Myelofibrosis Alabama keessatti

Qorannoo 7 Myelofibrosis f Alabama keessatti hirmaatuu jiru.

Magaalota Alabama keessatti

Takkalaa qorannoo (Ingiliffa)

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

  • University of Alabama, Birmingham
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT04176198

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

  • University of Alabama At Birmingham, Birmingham
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT07441694

UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy

  • University of Alabama at Birmingham, Birmingham
Namoota walitti qabaa jiraSadarkaa 1
4 Weeks – 75 Years · Saalaa hunda · Haaromfame 13-Elb-2026 · NCT06047886

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

  • University of Alabama Birmingham, Birmingham
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 66 · Saalaa hunda · Haaromfame 17-Bit-2026 · NCT06859424

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Birmingham
  • Massive Bio SYNERGY-AI site, Mobile
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

  • UAB Hospital, Birmingham
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2025 · NCT06479135

Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib

  • University of Alabama at Birmingham, Birmingham
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Gur-2023 · NCT05280509

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.